UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number: 811-05547
Laudus Trust
(Exact name of registrant as specified in charter)
211 Main Street, San Francisco, California 94105
(Address of principal executive offices) (Zip code)
Jonathan de St. Paer
Laudus Trust
211 Main Street, San Francisco, California 94105
(Name and address of agent for service)
Registrant’s telephone number, including area code: (415) 636-7000
Date of fiscal year end: March 31
Date of reporting period: March 31, 2022
Item 1: Report(s) to Shareholders.
Total Return for the 12 Months Ended March 31, 2022 | |
Schwab Select Large Cap Growth Fund (Ticker Symbol: LGILX) | 3.88% |
Russell 1000® Growth Index | 14.98% |
Performance Details | pages 5-7 |
President of Schwab Asset
Management and the fund
covered in this report.
Fund Characteristics | |
Number of Securities | 50 |
Weighted Average Market Cap (millions) | $762,670 |
Price/Earnings Ratio (P/E) | 35.95 |
Price/Book Ratio (P/B) | 9.29 |
Portfolio Turnover (One-year trailing) | 50% |
Fund Overview | |
Fund | |
Inception Date | 10/14/1997 * |
Ticker Symbol | LGILX |
Cusip | 51855Q549 |
NAV | $26.64 |
* | Inception date is that of the fund’s predecessor fund, the Class Y Shares of the UBS U.S. Large Cap Growth Fund. |
Fund and Inception Date | 1 Year | 5 Years | 10 Years |
Schwab Select Large Cap Growth Fund (10/14/97)1 | 3.88% | 18.76% | 15.26% |
Russell 1000® Growth Index | 14.98% | 20.88% | 17.04% |
Fund Expense Ratio2: 0.72% |
1 | Inception date is that of the fund’s predecessor fund, the Class Y Shares of the UBS U.S. Large Cap Growth Fund. |
2 | As stated in the prospectus. Reflects the total annual fund operating expenses without contractual fee waivers. For actual expense ratios during the period, refer to the Financial Highlights section of the Financial Statements. |
1 | The percentage may differ from the Portfolio Holdings because the above calculation is based on a percentage of total investments, whereas the calculation in the Portfolio Holdings is based on a percentage of net assets. |
2 | This list is not a recommendation of any security by the investment adviser or subadviser. |
EXPENSE RATIO (ANNUALIZED) 1 | BEGINNING ACCOUNT VALUE AT 10/1/21 | ENDING ACCOUNT VALUE (NET OF EXPENSES) AT 3/31/22 | EXPENSES PAID DURING PERIOD 10/1/21-3/31/222 | |
Schwab Select Large Cap Growth Fund | ||||
Actual Return | 0.71% | $1,000.00 | $ 915.90 | $3.39 |
Hypothetical 5% Return | 0.71% | $1,000.00 | $1,021.39 | $3.58 |
1 | Based on the most recent six-month expense ratio. |
2 | Expenses for the fund are equal to its annualized expense ratio, multiplied by the average account value over the period, multiplied by the 182 days of the period, and divided by the 365 days of the fiscal year. |
4/1/21– 3/31/22 | 4/1/20– 3/31/21 | 4/1/19– 3/31/20 | 4/1/18– 3/31/19 | 4/1/17– 3/31/18 | ||
Per-Share Data | ||||||
Net asset value at beginning of period | $29.23 | $19.61 | $21.31 | $20.47 | $18.12 | |
Income (loss) from investment operations: | ||||||
Net investment income (loss)1 | (0.09) | (0.07) | (0.04) | 0.02 | 0.00 2 | |
Net realized and unrealized gains (losses) | 1.69 | 11.21 | 0.23 | 2.35 | 4.99 | |
Total from investment operations | 1.60 | 11.14 | 0.19 | 2.37 | 4.99 | |
Less distributions: | ||||||
Distributions from net investment income | — | — | (0.02) | — | — | |
Distributions from net realized gains | (4.19) | (1.52) | (1.87) | (1.53) | (2.64) | |
Total distributions | (4.19) | (1.52) | (1.89) | (1.53) | (2.64) | |
Net asset value at end of period | $26.64 | $29.23 | $19.61 | $21.31 | $20.47 | |
Total return | 3.88% | 56.98% | (0.06%) | 12.78% | 28.52% | |
Ratios/Supplemental Data | ||||||
Ratios to average net assets: | ||||||
Net operating expenses | 0.71% | 0.72% | 0.74% | 0.75% | 0.75% 3 | |
Gross operating expenses | 0.71% | 0.72% | 0.74% | 0.75% | 0.75% 3 | |
Net investment income (loss) | (0.28%) | (0.25%) | (0.18%) | 0.07% | 0.01% 3 | |
Portfolio turnover rate | 50% | 37% | 40% | 53% | 49% | |
Net assets, end of period (x 1,000,000) | $2,926 | $2,943 | $1,981 | $2,251 | $1,953 |
1 | Calculated based on the average shares outstanding during the period. |
2 | Per-share amount was less than $0.005. |
3 | The ratio of net operating expenses and gross operating expenses would have been 0.76% and 0.76%, respectively, and the ratio of net investment income would have been less than 0.005%, excluding a custody out-of-pocket fee reimbursement from the custodian. |
SECURITY | NUMBER OF SHARES | VALUE ($) |
COMMON STOCKS 99.4% OF NET ASSETS | ||
Automobiles & Components 2.6% | ||
Tesla, Inc. * | 71,834 | 77,408,318 |
Capital Goods 3.1% | ||
Roper Technologies, Inc. | 54,422 | 25,699,701 |
TransDigm Group, Inc. * | 98,787 | 64,363,682 |
90,063,383 | ||
Commercial & Professional Services 0.6% | ||
TransUnion | 162,354 | 16,777,662 |
Consumer Durables & Apparel 4.4% | ||
LVMH Moet Hennessy Louis Vuitton SE ADR | 406,917 | 58,018,226 |
NIKE, Inc., Class B | 517,177 | 69,591,337 |
127,609,563 | ||
Consumer Services 4.1% | ||
Chipotle Mexican Grill, Inc. * | 40,515 | 64,095,946 |
Domino's Pizza, Inc. | 66,938 | 27,244,435 |
Evolution AB | 272,314 | 27,789,644 |
119,130,025 | ||
Diversified Financials 4.8% | ||
KKR & Co., Inc. | 758,568 | 44,353,471 |
S&P Global, Inc. | 236,766 | 97,116,678 |
141,470,149 | ||
Energy 2.7% | ||
EQT Corp. | 662,042 | 22,780,865 |
Pioneer Natural Resources Co. | 221,829 | 55,463,905 |
78,244,770 | ||
Health Care Equipment & Services 3.5% | ||
Align Technology, Inc. * | 111,611 | 48,662,396 |
Intuitive Surgical, Inc. * | 68,432 | 20,644,566 |
UnitedHealth Group, Inc. | 65,280 | 33,290,841 |
102,597,803 | ||
Household & Personal Products 0.6% | ||
Olaplex Holdings, Inc. * | 1,031,592 | 16,123,783 |
Materials 3.0% | ||
Ball Corp. | 167,573 | 15,081,570 |
Linde plc | 130,851 | 41,797,735 |
SECURITY | NUMBER OF SHARES | VALUE ($) |
The Sherwin-Williams Co. | 123,215 | 30,756,928 |
87,636,233 | ||
Media & Entertainment 11.1% | ||
Alphabet, Inc., Class A * | 57,589 | 160,175,165 |
Match Group, Inc. * | 394,891 | 42,940,447 |
Meta Platforms, Inc., Class A * | 133,029 | 29,580,328 |
Netflix, Inc. * | 86,869 | 32,540,259 |
Snap, Inc., Class A * | 1,662,625 | 59,837,874 |
325,074,073 | ||
Pharmaceuticals, Biotechnology & Life Sciences 6.5% | ||
10X Genomics, Inc., Class A * | 62,737 | 4,772,404 |
Danaher Corp. | 187,050 | 54,867,377 |
Eli Lilly & Co. | 68,008 | 19,475,451 |
Lonza Group AG ADR | 424,686 | 30,785,488 |
Thermo Fisher Scientific, Inc. | 53,339 | 31,504,680 |
Zoetis, Inc. | 260,951 | 49,212,749 |
190,618,149 | ||
Retailing 10.5% | ||
Amazon.com, Inc. * | 83,126 | 270,986,604 |
Etsy, Inc. * | 299,753 | 37,253,303 |
308,239,907 | ||
Semiconductors & Semiconductor Equipment 9.5% | ||
Applied Materials, Inc. | 128,448 | 16,929,446 |
ASML Holding N.V. NY Registry Shares | 123,056 | 82,192,794 |
Marvell Technology, Inc. | 997,853 | 71,556,039 |
NVIDIA Corp. | 393,260 | 107,304,924 |
277,983,203 | ||
Software & Services 27.1% | ||
Adobe, Inc. * | 97,892 | 44,601,553 |
Bill.com Holdings, Inc. * | 110,163 | 24,983,867 |
Crowdstrike Holdings, Inc., Class A * | 83,358 | 18,928,935 |
Intuit, Inc. | 235,785 | 113,374,859 |
Mastercard, Inc., Class A | 150,678 | 53,849,304 |
Microsoft Corp. | 1,004,698 | 309,758,440 |
MongoDB, Inc. * | 81,785 | 36,279,008 |
ServiceNow, Inc. * | 124,104 | 69,112,276 |
Snowflake, Inc., Class A * | 163,420 | 37,444,425 |
Visa, Inc., Class A | 381,888 | 84,691,302 |
793,023,969 | ||
Technology Hardware & Equipment 5.3% | ||
Apple Inc. | 654,387 | 114,262,514 |
Zebra Technologies Corp., Class A * | 101,733 | 42,086,942 |
156,349,456 | ||
Total Common Stocks (Cost $1,778,930,153) | 2,908,350,446 |
SECURITY | NUMBEROF SHARES | VALUE ($) |
SHORT-TERM INVESTMENTS 0.2% OF NET ASSETS | ||
Money Market Funds 0.2% | ||
State Street Institutional U.S. Government Money Market Fund, Premier Class 0.25% (a) | 5,224,920 | 5,224,920 |
Total Short-Term Investments (Cost $5,224,920) | 5,224,920 | |
Total Investments in Securities (Cost $1,784,155,073) | 2,913,575,366 |
* | Non-income producing security. |
(a) | The rate shown is the 7-day yield. |
ADR — | American Depositary Receipt |
DESCRIPTION | QUOTED PRICES IN ACTIVE MARKETS FOR IDENTICAL ASSETS (LEVEL 1) | OTHER SIGNIFICANT OBSERVABLE INPUTS (LEVEL 2) | SIGNIFICANT UNOBSERVABLE INPUTS (LEVEL 3) | TOTAL |
Assets | ||||
Common Stocks1 | $2,908,350,446 | $— | $— | $2,908,350,446 |
Short-Term Investments1 | 5,224,920 | — | — | 5,224,920 |
Total | $2,913,575,366 | $— | $— | $2,913,575,366 |
1 | As categorized in the Portfolio Holdings. |
Assets | ||
Investments in securities, at value - unaffiliated (cost $1,784,155,073) | $2,913,575,366 | |
Receivables: | ||
Investments sold | 21,996,394 | |
Fund shares sold | 3,056,542 | |
Dividends | 238,625 | |
Foreign tax reclaims | 12,961 | |
Prepaid expenses | + | 19,741 |
Total assets | 2,938,899,629 | |
Liabilities | ||
Payables: | ||
Investments bought | 6,173,116 | |
Fund shares redeemed | 4,525,214 | |
Investment adviser fees | 1,452,632 | |
Sub-accounting and sub-transfer agent fees | 249,598 | |
Accrued expenses | + | 149,613 |
Total liabilities | 12,550,173 | |
Net assets | $2,926,349,456 | |
Net Assets by Source | ||
Capital received from investors | $1,584,867,937 | |
Total distributable earnings | + | 1,341,481,519 |
Net assets | $2,926,349,456 |
Net Asset Value (NAV) | ||||
Net Assets | ÷ | Shares Outstanding | = | NAV |
$2,926,349,456 | 109,855,444 | $26.64 | ||
For the period April 1, 2021 through March 31, 2022 | ||
Investment Income | ||
Dividends received from securities - unaffiliated (net of foreign withholding tax of $157,226) | $13,941,912 | |
Expenses | ||
Investment adviser fees | 19,372,143 | |
Sub-accounting and sub-transfer agent fees | 2,979,139 | |
Accounting and administration fees | 114,326 | |
Shareholder reports | 95,849 | |
Independent trustees’ fees | 79,855 | |
Registration fees | 76,264 | |
Professional fees | 56,946 | |
Custodian fees | 32,668 | |
Transfer agent fees | 17,301 | |
Other expenses | + | 35,205 |
Total expenses | – | 22,859,696 |
Net investment loss | (8,917,784) | |
REALIZED AND UNREALIZED GAINS (LOSSES) | ||
Net realized gains on sales of securities - unaffiliated | 414,266,125 | |
Net change in unrealized appreciation (depreciation) on securities - unaffiliated | + | (288,057,571) |
Net realized and unrealized gains | 126,208,554 | |
Increase in net assets resulting from operations | $117,290,770 |
OPERATIONS | |||
4/1/21-3/31/22 | 4/1/20-3/31/21 | ||
Net investment loss | ($8,917,784) | ($6,754,526) | |
Net realized gains | 414,266,125 | 291,071,501 | |
Net change in unrealized appreciation (depreciation) | + | (288,057,571) | 845,317,794 |
Increase in net assets resulting from operations | $117,290,770 | $1,129,634,769 | |
DISTRIBUTIONS TO SHAREHOLDERS | |||
Total distributions | ($413,156,206) | ($151,866,592) |
TRANSACTIONS IN FUND SHARES | |||||
4/1/21-3/31/22 | 4/1/20-3/31/21 | ||||
SHARES | VALUE | SHARES | VALUE | ||
Shares sold | 17,230,277 | $533,578,230 | 21,504,281 | $570,122,715 | |
Shares reinvested | 11,156,502 | 334,471,940 | 4,381,621 | 125,708,707 | |
Shares redeemed | + | (19,204,653) | (588,640,294) | (26,212,855) | (711,620,716) |
Net transactions in fund shares | 9,182,126 | $279,409,876 | (326,953) | ($15,789,294) | |
SHARES OUTSTANDING AND NET ASSETS | |||||
4/1/21-3/31/22 | 4/1/20-3/31/21 | ||||
SHARES | NET ASSETS | SHARES | NET ASSETS | ||
Beginning of period | 100,673,318 | $2,942,805,016 | 101,000,271 | $1,980,826,133 | |
Total increase (decrease) | + | 9,182,126 | (16,455,560) | (326,953) | 961,978,883 |
End of period | 109,855,444 | $2,926,349,456 | 100,673,318 | $2,942,805,016 |
3. Risk Factors: |
% OF AVERAGE DAILY NET ASSETS | |
First $500 million | 0.700% |
$500 million to $1 billion | 0.650% |
$1 billion to $1.5 billion | 0.600% |
$1.5 billion to $2 billion | 0.575% |
Over $2 billion | 0.550% |
Schwab Balanced Fund | 4.0% |
Schwab Target 2010 Fund | 0.0%* |
Schwab Target 2015 Fund | 0.0%* |
Schwab Target 2020 Fund | 0.2% |
Schwab Target 2025 Fund | 0.5% |
Schwab Target 2030 Fund | 1.3% |
Schwab Target 2035 Fund | 0.9% |
Schwab Target 2040 Fund | 2.1% |
Schwab Target 2045 Fund | 0.6% |
Schwab Target 2050 Fund | 0.6% |
Schwab Target 2055 Fund | 0.5% |
Schwab Target 2060 Fund | 0.1% |
Schwab Target 2065 Fund | 0.0%* |
* | Less than 0.05% |
PURCHASES OF SECURITIES | SALES OF SECURITIES |
$1,592,847,843 | $1,755,333,680 |
TAX COST | GROSS UNREALIZED APPRECIATION | GROSS UNREALIZED DEPRECIATION | NET UNREALIZED APPRECIATION (DEPRECIATION) |
$1,790,167,213 | $1,231,196,351 | ($107,788,198) | $1,123,408,153 |
UNDISTRIBUTED LONG-TERM CAPITAL GAINS | NET UNREALIZED APPRECIATION (DEPRECIATION) ON INVESTMENTS | CAPITAL LOSS CARRYFORWARDS AND OTHER LOSSES | TOTAL |
$219,991,462 | $1,123,408,153 | ($1,918,096) | $1,341,481,519 |
CURRENT FISCAL YEAR END DISTRIBUTIONS | PRIOR FISCAL YEAR END DISTRIBUTIONS | |||
ORDINARY INCOME | LONG-TERM CAPITAL GAINS | ORDINARY INCOME | LONG-TERM CAPITAL GAINS | |
$14,751,631 | $398,404,575 | $— | $151,866,592 |
9. Subsequent Events: |
Denver, Colorado
May 17, 2022
Independent Trustees | |||
Name, Year of Birth, and Position(s) with the trust (Terms of office, and length of Time Served1) | Principal Occupations During the Past Five Years | Number of Portfolios in Fund Complex Overseen by the Trustee | Other Directorships |
Robert W. Burns 1959 Trustee (Trustee of Schwab Strategic Trust since 2009; The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios and Laudus Trust since 2016) | Retired/Private Investor. | 103 | None |
Nancy F. Heller 1956 Trustee (Trustee of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios, Schwab Strategic Trust and Laudus Trust since 2018) | Retired. | 103 | None |
David L. Mahoney 1954 Trustee (Trustee of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios and Laudus Trust since 2011; Schwab Strategic Trust since 2016) | Private Investor. | 103 | Director (2004 – present), Corcept Therapeutics Incorporated Director (2009 – 2021), Adamas Pharmaceuticals, Inc. Director (2003 – 2019), Symantec Corporation |
Jane P. Moncreiff 1961 Trustee (Trustee of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios, Schwab Strategic Trust and Laudus Trust since 2019) | Consultant (2018 – present), Fulham Advisers LLC (management consulting); Chief Investment Officer (2009 – 2017), CareGroup Healthcare System, Inc. (healthcare). | 103 | None |
Kiran M. Patel 1948 Trustee (Trustee of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios and Laudus Trust since 2011; Schwab Strategic Trust since 2016) | Retired. | 103 | Director (2008 – present), KLA-Tencor Corporation |
Independent Trustees (continued) | |||
Name, Year of Birth, and Position(s) with the trust (Terms of office, and length of Time Served1) | Principal Occupations During the Past Five Years | Number of Portfolios in Fund Complex Overseen by the Trustee | Other Directorships |
Kimberly S. Patmore 1956 Trustee (Trustee of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios, Schwab Strategic Trust and Laudus Trust since 2016) | Consultant (2008 – present), Patmore Management Consulting (management consulting). | 103 | None |
J. Derek Penn 1957 Trustee (Trustee of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios, Schwab Strategic Trust and Laudus Trust since 2021) | Head of Equity Sales and Trading (2006 – 2018), BNY Mellon (financial services). | 103 | None |
Interested Trustees | |||
Name, Year of Birth, and Position(s) with the trust (Terms of office, and length of Time Served1) | Principal Occupations During the Past Five Years | Number of Portfolios in Fund Complex Overseen by the Trustee | Other Directorships |
Walter W. Bettinger II2 1960 Chairman and Trustee (Trustee of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust and Schwab Annuity Portfolios since 2008; Schwab Strategic Trust since 2009; Laudus Trust since 2010) | Director and Chief Executive Officer (Oct. 2008 – present) and President (Feb. 2007 – Oct. 2021), The Charles Schwab Corporation; President and Chief Executive Officer (Oct. 2008 – Oct. 2021) and Director (May 2008 – Oct. 2021), Charles Schwab & Co., Inc.; Director (Apr. 2006 – present), Charles Schwab Bank, SSB; Director (Nov. 2017 – present), Charles Schwab Premier Bank, SSB; Director (July 2019 – present), Charles Schwab Trust Bank; Director (May 2008 – present) and President and Chief Executive Officer (Aug. 2017 – present), Schwab Holdings, Inc.; Director (Oct. 2020 – present), TD Ameritrade Holding Corporation; Director (July 2016 – Oct. 2021), Charles Schwab Investment Management, Inc. | 103 | Director (2008 – present), The Charles Schwab Corporation |
Joseph R. Martinetto2 1962 Trustee (Trustee of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios, Schwab Strategic Trust and Laudus Trust since 2016) | Chief Operating Officer (Feb. 2018 – present), The Charles Schwab Corporation; Senior Executive Vice President (July 2015 – present), Charles Schwab & Co., Inc.; Director (May 2007 – present), Charles Schwab & Co., Inc.; Director (Apr. 2010 – Apr. 2020), Charles Schwab Bank, SSB; Director (Nov. 2017 – Apr. 2020), Charles Schwab Premier Bank, SSB; Director (May 2007 – Apr. 2020), and Senior Executive Vice President (Feb. 2016 – present), Schwab Holdings, Inc.; Director (Oct. 2020 – present), TD Ameritrade Holding Corporation. | 103 | None |
Officers of the Trust | |
Name, Year of Birth, and Position(s) with the trust (Terms of office, and length of Time Served3) | Principal Occupations During the Past Five Years |
Jonathan de St. Paer 1973 President and Chief Executive Officer (Officer of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios, Schwab Strategic Trust and Laudus Trust since 2018) | Director (Apr. 2019 – present), President (Oct. 2018 – present), Chief Operating Officer (Jan. 2020 – present), and Chief Executive Officer (Apr. 2019 – Nov. 2019), Charles Schwab Investment Management, Inc.; Senior Vice President (June 2020 – Mar. 2022) and Chief Operating Officer (Jan. 2020 – Mar. 2022), Charles Schwab Investment Advisory, Inc.; Chief Executive Officer (Apr. 2019 – present), President (Nov. 2018 – present) and Trustee (Apr. 2019 – Dec. 2020), Schwab Funds, Laudus Trust and Schwab ETFs; Director (Apr. 2019 – Apr. 2022), Charles Schwab Worldwide Funds plc and Charles Schwab Asset Management (Ireland) Limited; Senior Vice President (Apr. 2019 – present), and Senior Vice President – Strategy and Product Development (CSIM) (Jan. 2014 – Mar. 2019), Charles Schwab & Co., Inc. |
Mark Fischer 1970 Treasurer, Chief Financial Officer and Chief Operating Officer (Officer of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios, Schwab Strategic Trust and Laudus Trust since 2013) | Treasurer and Chief Financial Officer (Jan. 2016 – present) and Chief Operating Officer (Dec. 2020 – present), Schwab Funds, Laudus Trust and Schwab ETFs; Chief Financial Officer (Mar. 2020 – present) and Vice President (Oct. 2013 – present), Charles Schwab Investment Management, Inc.; Director (July 2020 – Apr. 2022), Charles Schwab Worldwide Funds plc and Charles Schwab Asset Management (Ireland) Limited. |
Omar Aguilar 1970 Vice President and Chief Investment Officer (Officer of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios, Schwab Strategic Trust and Laudus Trust since 2011) | Chief Executive Officer (Jan. 2022 – present) and Chief Investment Officer (Apr. 2011 – present), Senior Vice President (Apr. 2011 – Dec. 2021), Charles Schwab Investment Management, Inc.; Vice President and Chief Investment Officer (June 2011 – present), Schwab Funds, Laudus Trust and Schwab ETFs. |
Brett Wander 1961 Vice President and Chief Investment Officer (Officer of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios, Schwab Strategic Trust and Laudus Trust since 2011) | Senior Vice President and Chief Investment Officer (Apr. 2011 – present), Charles Schwab Investment Management, Inc.; Vice President and Chief Investment Officer (June 2011 – present), Schwab Funds, Laudus Trust and Schwab ETFs. |
William P. McMahon, Jr. 1972 Vice President and Chief Investment Officer (Officer of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios, Schwab Strategic Trust and Laudus Trust since 2021) | Senior Vice President and Chief Investment Officer (Jan. 2020 – present), Charles Schwab Investment Management, Inc.; Vice President and Chief Investment Officer (June 2021 – present), Schwab Funds, Laudus Trust and Schwab ETFs; Senior Vice President and Chief Investment Officer – ThomasPartners Strategies (Apr. 2018 – Dec. 2019), Charles Schwab Investment Advisory, Inc.; Senior Vice President and Chief Investment Officer (May 2001 – Apr. 2018), ThomasPartners, Inc. |
Catherine MacGregor 1964 Chief Legal Officer and Secretary, Schwab Funds and Schwab ETFs Chief Legal Officer, Vice President and Clerk, Laudus Trust (Officer of The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios and Laudus Trust since 2005; Schwab Strategic Trust since 2009) | Chief Legal Officer (Mar. 2022 – present) and Vice President (Sept. 2005 – present), Charles Schwab Investment Management, Inc.; Vice President (July 2005 – present), Charles Schwab & Co., Inc.; Vice President (Dec. 2005 – present) and Chief Legal Officer and Clerk (Mar. 2007 – present), Laudus Trust; Chief Legal Officer and Secretary (Oct. 2021 – present), Vice President (Nov. 2005 – Oct. 2021) and Assistant Secretary (June 2007 – Oct. 2021), Schwab Funds; Chief Legal Officer and Secretary (Oct. 2021 – present), Vice President and Assistant Secretary (Oct. 2009 – Oct. 2021), Schwab ETFs. |
1 | Each Trustee shall hold office until the election and qualification of his or her successor, or until he or she dies, resigns or is removed. The retirement policy requires that each independent trustee retire by December 31 of the year in which the Trustee turns 74 or the Trustee’s twentieth year of service as an independent trustee on any trust in the Fund Complex, whichever occurs first. |
2 | Mr. Bettinger and Mr. Martinetto are Interested Trustees. Mr. Bettinger is an Interested Trustee because he owns stock of The Charles Schwab Corporation (CSC), the parent company of Charles Schwab Investment Management, Inc., the investment adviser for the trusts in the Fund Complex, and is an employee of Charles Schwab & Co., Inc. (Schwab), the principal underwriter for The Charles Schwab Family of Funds, Schwab Investments, Schwab Capital Trust, Schwab Annuity Portfolios and Laudus Trust. Mr. Martinetto is an Interested Trustee because he owns stock of CSC and is an employee and director of Schwab. |
3 | The President, Treasurer and Secretary/Clerk hold office until their respective successors are chosen and qualified or until he or she sooner dies, resigns, is removed or becomes disqualified. Each of the other officers serves at the pleasure of the Board. |
Schwab Funds
Member SIPC®
Printed on recycled paper.
¹ | State, local, and the Federal Alternative Minimum Tax may apply. Capital gains are not exempt from Federal Taxation. |
² | You could lose money by investing in the Schwab Money Funds. All Schwab Money Funds with the exception of Schwab Variable Share Price Money Fund seek to preserve the value of your investment at $1.00 per share, but cannot guarantee they will do so. Because the share price of Schwab Variable Share Price Money Fund will fluctuate, when you sell your shares they may be worth more or less than what you originally paid for them. All Schwab Money Funds with the exception of Schwab Government Money Fund, Schwab Retirement Government Money Fund, Schwab U.S. Treasury Money Fund, Schwab Treasury Obligations Money Fund and Schwab Government Money Market Portfolio may impose a fee upon the sale of your shares or may temporarily suspend your ability to sell shares if the Fund’s liquidity falls below required minimums because of market conditions or other factors. An investment in the Schwab Money Funds is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. The Schwab Money Funds’ sponsor has no legal obligation to provide financial support to the Funds, and you should not expect that the sponsor will provide financial support to the Funds at any time. |
Item 2: Code of Ethics.
(a) | Registrant has adopted a code of ethics that applies to its principal executive officer, principal financial officer, and any other persons who perform a similar function, regardless of whether these individuals are employed by Registrant or a third party. |
(c) | During the period covered by the report, no amendments were made to the provisions of this code of ethics. |
(d) | During the period covered by the report, Registrant did not grant any waivers, including implicit waivers, from the provisions of this code of ethics. |
(f)(1) | Registrant has filed this code of ethics as an exhibit pursuant to Item 13(a)(1) of Form N-CSR. |
Item 3: Audit Committee Financial Expert.
Registrant’s Board of Trustees has determined that Kiran M. Patel, Kimberly S. Patmore and J. Derek Penn, each currently serving on its audit, compliance and valuation committee, are each an “audit committee financial expert,” as such term is defined in Item 3 of Form N-CSR. Each member of Registrant’s audit, compliance and valuation committee is “independent” under the standards set forth in Item 3 of Form N-CSR.
The designation of each of Mr. Patel, Ms. Patmore and Mr. Penn as an “audit committee financial expert” pursuant to Item 3 of Form N-CSR does not (i) impose upon such individual any duties, obligations, or liability that are greater than the duties, obligations and liability imposed upon such individual as a member of Registrant’s audit, compliance and valuation committee or Board of Trustees in the absence of such designation; and (ii) affect the duties, obligations or liability of any other member of Registrant’s audit, compliance and valuation committee or Board of Trustees.
Item 4: Principal Accountant Fees and Services.
Registrant is composed of one series which has a fiscal year-end of March 31, whose annual financial statements are reported in Item 1. Principal accountant fees disclosed in Items 4(a)-(d) and 4(g) include fees billed for services rendered to the operational series during 2022 and 2021 fiscal years, as applicable.
The following table presents fees billed by the principal accountant in each of the last two fiscal years for the services rendered to the Funds:
(a)Audit Fees1 | (b)Audit-Related Fees | (c) Tax Fees2 | (d) All Other Fees | |||||||||||
Fiscal Year 2022 | Fiscal Year 2021 | Fiscal Year 2022 | Fiscal Year 2021 | Fiscal Year 2022 | Fiscal Year 2021 | Fiscal Year 2022 | Fiscal Year 2021 | |||||||
$31,080 | $31,080 | $0 | $0 | $3,100 | $3,100 | $0 | $0 |
1 | The nature of the services includes audit of the registrant’s annual financial statements and normally provided services in connection with regulatory filings for those fiscal years. |
2 | The nature of the services includes tax compliance, tax advice and tax planning. |
(e)(1) Registrant’s audit, compliance and valuation committee does not have pre-approval policies and procedures as described in paragraph (c)(7) of Rule 2-01 of Regulation S-X.
(2) There were no services described in each of paragraphs (b) through (d) above (including services required to be approved by Registrant’s audit, compliance and valuation committee pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X) that were approved by Registrant’s audit, compliance and valuation committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.
(f) Not applicable.
(g) Below are the aggregate non-audit fees billed in each of the last two fiscal years by Registrant’s principal accountant for services rendered to Registrant, to Registrant’s investment adviser, and to any entity controlling, controlled by, or under common control with Registrant’s investment adviser that provides ongoing services to Registrant.
2022: $2,320,631 2021: $4,663,610
(h) During the past fiscal year, all non-audit services provided by Registrant’s principal accountant to either Registrant’s investment adviser or to any entity controlling, controlled by, or under common control with Registrant’s investment adviser that provides ongoing services to Registrant were pre-approved. Included in the audit, compliance and valuation committee’s pre-approval was the review and consideration as to whether the provision of these non-audit services is compatible with maintaining the principal accountant’s independence.
Item 5: Audit Committee of Listed Registrants.
Not applicable.
Item 6: Schedule of Investments.
The schedules of investments are included as part of the report to shareholders filed under Item 1 of this Form.
Item 7: Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 8: Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 9: Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 10: Submission of Matters to a Vote of Security Holders.
Not applicable.
Item 11: Controls and Procedures.
(a) Based on their evaluation of Registrant’s disclosure controls and procedures, as of a date within 90 days of the filing date, Registrant’s Chief Executive Officer, Jonathan de St. Paer and Registrant’s Chief Financial Officer, Mark Fischer, have concluded that Registrant’s disclosure controls and procedures are: (i) reasonably designed to ensure that information required to be disclosed in this report is appropriately communicated to Registrant’s officers to allow timely decisions regarding disclosures required in this report; (ii) reasonably designed to ensure that information required to be disclosed in this report is recorded, processed, summarized and reported in a timely manner; and (iii) are effective in achieving the goals described in (i) and (ii) above.
(b) During the period covered by this report, there have been no changes in Registrant’s internal control over financial reporting that the above officers believe to have materially affected, or to be reasonably likely to materially affect, Registrant’s internal control over financial reporting.
Item 12: Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 13: Exhibits.
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
(Registrant) Laudus Trust
By: | /s/ Jonathan de St. Paer | |
Jonathan de St. Paer Chief Executive Officer | ||
Date: | May 17, 2022 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: | /s/ Jonathan de St. Paer | |
Jonathan de St. Paer Chief Executive Officer | ||
Date: | May 17, 2022 |
By: | /s/ Mark Fischer | |
Mark Fischer Chief Financial Officer | ||
Date: | May 17, 2022 |